Breaking News
Get 40% Off 0
👀 Reveal Warren Buffett's stock picks that are beating the S&P 500 by +174.3% Get 40% Off

3 Dividend Stocks to Watch as Earnings Season Heats Up

By Investing.com (Damian Nowiszewski)Stock MarketsJul 27, 2023 08:08AM ET
www.investing.com/analysis/3-dividend-stocks-to-watch-as-earnings-season-heats-up-200640423
3 Dividend Stocks to Watch as Earnings Season Heats Up
By Investing.com (Damian Nowiszewski)   |  Jul 27, 2023 08:08AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
AZN
-1.10%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
CL
+0.08%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
PG
+0.28%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AZN
-1.44%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
  • Tomorrow, long-standing dividend companies will announce their earnings.
  • Ahead of the earnings, Colgate-Palmolive stock is undergoing a consolidation
  • Meanwhile, Proctor & Gamble stock faces resistance, and AstraZeneca stock has decent upside potential

As earnings season begins to wind down for the growth giants, it is time for investors to turn some of their attention back to the dividend-paying value giants of the market, with Colgate-Palmolive (NYSE:CL), AstraZeneca (NASDAQ:AZN), and Procter & Gamble (NYSE:PG) all poised to deliver important reports over the next few market sessions.

Ahead of the report, Colgate-Palmolive's stock has been undergoing consolidation for over two months, indicating anticipation of a potential breakout following tomorrow's earnings.

Meanwhile, AstraZeneca's stock has faced challenges driven by negative sentiment surrounding clinical trial results. Investors will be closely watching the forthcoming earnings report for potential insights regarding this.

Lastly, Procter & Gamble continues to maintain its reputation as a stalwart defensive company, maintaining stability over the years and appealing to investors seeking a defensive addition to their portfolio.

Let's take a closer look at each of these companies individually to assess their financial performance going into earnings.

1. Colgate-Palmolive: Time to Break Out of Consolidation?

Colgate-Palmolive, a well-known consumer staples company, is gearing up to unveil its highly anticipated third-quarter 2023 results this Friday. Market forecasts suggest that the company's earnings per share are expected to reach $0.75, accompanied by impressive revenues of $4.696 billion.

CL Upcoming Earnings
CL Upcoming Earnings
Source: InvestingPro

For over two months, the stock has remained in a local consolidation phase, creating a situation where better-than-forecast readings in tomorrow's report could potentially trigger a breakout in an upward direction.

CL Price Chart
CL Price Chart

Looking at the bigger picture, the stock is still following a long-term uptrend, albeit within a broader correction pattern. This suggests that despite the short-term consolidation, the overall trajectory of the stock remains positive, and there is potential for a rally.

CL Price Chart
CL Price Chart

Breaking the upper limit of the long-term flag formation, in this case, will be crucial for the continuation of the uptrend.

2. AstraZeneca's Stock Has Continued to Climb

Earlier this month, AstraZeneca released a report on the results of a clinical trial for a new lung cancer drug developed in collaboration with Japanese company Daiichi Sankyo (TYO:4568). However, the findings disappointed investors as they didn't confirm a clinically significant outcome.

The drug was also expected to match or surpass the success of its predecessor, Enheret, which raised hopes among investors.

Nevertheless, AstraZeneca remains determined to continue the study and plans to submit a comprehensive report to regulatory authorities for review. Despite the initial setback, the company holds optimism for the drug's future potential.

Regarding earnings per share, the projections have remained unchanged since the Q1 results, with the current reading at $0.97 per share, compared to the previous figure of $0.96. Interestingly, the market has seen buyers making up some of the losses, suggesting a potential continuation of the upward trend.

In fact, fair value assessments show nearly 20% upside potential for the stock, indicating a positive outlook. Despite the recent challenges in the clinical trial, investors may find reasons to remain hopeful about the company's prospects going forward.

AZN Fair Value
AZN Fair Value
Source: InvestingPro

3. Procter & Gamble Stock Faces Resistance

Procter & Gamble is a well-known and highly regarded consumer staples company. Renowned for its strong brand presence in the market, it serves as a reliable choice for a defensive portfolio position.

One notable aspect of Procter & Gamble is its impressive dividend payment history, which stands as the longest among the three companies analyzed. Over the past decade, the company has consistently increased its dividends, further adding to its appeal to income-seeking investors.

With its solid reputation, stable performance, and consistent dividend growth, Procter & Gamble continues to be an attractive option for investors looking for a reliable and defensive addition to their portfolio.

PG Dividend Payout History
PG Dividend Payout History
Source: InvestingPro

Tomorrow's earnings are likely to show a continuation of the recent trend where earnings per share deviations have been relatively small. Investors will be paying close attention to any guidance or forecasts provided by the company for future reporting periods, as these can have a significant impact on market sentiment.

The current base scenario suggests that the upward trend will continue, and if the stock manages to break through the $158 per share level, it could open the path for an attempt to reach the historical highs set at the beginning of last year.

PG Price Chart
PG Price Chart

***

Summer Sale Is Live!
Summer Sale Is Live!

Disclaimer: This article is written for informational purposes only; it does not constitute a solicitation, offer, advice, counsel, or recommendation to invest as such it is not intended to incentivize the purchase of assets in any way. As a reminder, any type of asset is evaluated from multiple points of view and is highly risky and, therefore, any investment decision and the associated risk remains with the investor. The author owns the stocks mentioned in the analysis.

3 Dividend Stocks to Watch as Earnings Season Heats Up
 

Related Articles

3 Dividend Stocks to Watch as Earnings Season Heats Up

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email